565 related articles for article (PubMed ID: 33258577)
1. Mechanical Immunoengineering of T cells for Therapeutic Applications.
Lei K; Kurum A; Tang L
Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
[TBL] [Abstract][Full Text] [Related]
2. Evidence and therapeutic implications of biomechanically regulated immunosurveillance in cancer and other diseases.
Mittelheisser V; Gensbittel V; Bonati L; Li W; Tang L; Goetz JG
Nat Nanotechnol; 2024 Mar; 19(3):281-297. PubMed ID: 38286876
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
Rhodes KR; Green JJ
Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
[TBL] [Abstract][Full Text] [Related]
4. Engineering vaccines and niches for immune modulation.
Purwada A; Roy K; Singh A
Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
[TBL] [Abstract][Full Text] [Related]
5. Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns.
Resetca D; Neschadim A; Medin JA
J Immunother; 2016 Sep; 39(7):249-59. PubMed ID: 27488725
[TBL] [Abstract][Full Text] [Related]
6. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
Xie YQ; Wei L; Tang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
[TBL] [Abstract][Full Text] [Related]
7. Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.
Han C; Kwon BS
Immunotherapy; 2018 Mar; 10(3):221-234. PubMed ID: 29370727
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
Froimchuk E; Carey ST; Edwards C; Jewell CM
Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances and future challenges in cancer immunotherapy].
Okuyama N; Tamada K; Tamura H
Rinsho Ketsueki; 2016; 57(11):2388-2395. PubMed ID: 27941290
[TBL] [Abstract][Full Text] [Related]
10. Mechanotransduction in T Cell Development, Differentiation and Function.
Rushdi M; Li K; Yuan Z; Travaglino S; Grakoui A; Zhu C
Cells; 2020 Feb; 9(2):. PubMed ID: 32033255
[TBL] [Abstract][Full Text] [Related]
11. Mechanobiology of mesenchymal stem cells: Perspective into mechanical induction of MSC fate.
Hao J; Zhang Y; Jing D; Shen Y; Tang G; Huang S; Zhao Z
Acta Biomater; 2015 Jul; 20():1-9. PubMed ID: 25871537
[TBL] [Abstract][Full Text] [Related]
12. Magnetic Nanotweezers for Interrogating Biological Processes in Space and Time.
Kim JW; Jeong HK; Southard KM; Jun YW; Cheon J
Acc Chem Res; 2018 Apr; 51(4):839-849. PubMed ID: 29589897
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy.
Huang Y; Li D; Qin DY; Gou HF; Wei W; Wang YS; Wei YQ; Wang W
Gene Ther; 2018 Jun; 25(3):192-197. PubMed ID: 28820501
[TBL] [Abstract][Full Text] [Related]
14. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
Cho SF; Anderson KC; Tai YT
Front Immunol; 2018; 9():1821. PubMed ID: 30147690
[TBL] [Abstract][Full Text] [Related]
15. T Cell Engineering.
Pircher M; Schirrmann T; Petrausch U
Prog Tumor Res; 2015; 42():110-35. PubMed ID: 26383243
[TBL] [Abstract][Full Text] [Related]
16. T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.
Sackstein R; Schatton T; Barthel SR
Lab Invest; 2017 Jun; 97(6):669-697. PubMed ID: 28346400
[TBL] [Abstract][Full Text] [Related]
17. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.
Kagoya Y; Tanaka S; Guo T; Anczurowski M; Wang CH; Saso K; Butler MO; Minden MD; Hirano N
Nat Med; 2018 Mar; 24(3):352-359. PubMed ID: 29400710
[TBL] [Abstract][Full Text] [Related]
18. Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells.
Elahi R; Khosh E; Tahmasebi S; Esmaeilzadeh A
Front Immunol; 2018; 9():1717. PubMed ID: 30108584
[TBL] [Abstract][Full Text] [Related]
19. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies.
Ye B; Smerin D; Gao Q; Kang C; Xiong X
Cancer Lett; 2018 Mar; 416():42-56. PubMed ID: 29247824
[TBL] [Abstract][Full Text] [Related]
20. Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.
Kean LS; Turka LA; Blazar BR
Immunol Rev; 2017 Mar; 276(1):192-212. PubMed ID: 28258702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
